Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Transaminase Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117467733B reveals immobilized transaminase process for Sitagliptin. Achieve high optical purity and cost reduction in API manufacturing with scalable biocatalysis.
Patent CN109576238A reveals efficient transaminase route for chiral beta-amino alcohols. Enables cost reduction and high-purity supply for pharmaceutical intermediates manufacturing.
Patent CN106801043B reveals high-efficiency enzymatic synthesis for Sitagliptin intermediates, offering superior purity and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN114075557B reveals enzymatic synthesis for high-purity Larotrectinib intermediate. Achieve cost reduction and scalable supply chain reliability.
Patent CN119530189A reveals green enzymatic route for cyclohexylamine. Offers high selectivity and reduced environmental impact for pharmaceutical intermediate supply chains.
Patent CN113881720B reveals enzymatic synthesis for high-purity intermediates. Achieve cost reduction and supply chain reliability with scalable biocatalysis.
Patent CN117070577A reveals dual-enzyme cascade for high-purity L-glufosinate. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN108660122A details high-efficiency transaminase mutant for L-glufosinate-ammonium production offering significant supply chain and cost advantages for global agrochemical manufacturers.
Novel chemo-enzymatic route for diabetes drug intermediate offers high purity and scalable manufacturing solutions for global pharmaceutical supply chains efficiently.
Patent CN110129306A details immobilized transaminase for besifloxacin intermediates. Offers high purity, reusability, and scalable manufacturing solutions for global pharmaceutical supply chains.
Patent CN118374468B reveals mutant transaminase for high yield chiral amine intermediate production with improved stereoselectivity.
Novel enzymatic synthesis method for high-purity chiral cis-cyclohexanediamine. Scalable process reduces impurities and ensures supply chain reliability for anticoagulant manufacturing.
Patent CN107586796A reveals enzymatic synthesis for high-purity chiral amines. Offers scalable cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Improved transaminase catalysis for sitagliptin reduces solvent use and enhances purity for reliable pharmaceutical intermediate supply chains.